Basic Information
| LncRNA/CircRNA Name | lncRNA-SRA1 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR etc. |
| Sample | HCC tissues, cell line (HepG2) |
| Expression Pattern | down-regulated |
| Function Description | The results indicated that the expression levels of SRA1 in HCC were remarkably decreased, compared with matched normal tissues. Levels of SRA1 in HCC cell lines were also significantly decreased than that in normal human hepatocyte cell line L-02. Additionally, the levels of SRA1 were significantly associated with tumor size and serum GLU level. |
| Pubmed ID | 28085012 |
| Year | 2017 |
| Title | Decreased expression of LncRNA SRA1 in hepatocellular carcinoma and its clinical significance. |
External Links
| Links for lncRNA-SRA1 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |